Core Scientific stock pullback deepens amid continued selloff pressure

Traders Union
All News
Stocks
Core Scientific slides 4.03% today

Highlights

Core Scientific secured $600 million in senior secured credit facilities, including a $100 million revolving line and a $500 million letter of credit.
The financing provides increased operational liquidity and greater flexibility for the company in managing financial obligations.
Shares of Core Scientific settled at $16.91, down 4.03%, and trade below key moving averages with high probability of further downside toward $16.3.

Expanded credit package fails to reverse negative share momentum

Core Scientific, Inc. has secured $600 million in senior secured credit facilities, including a $100 million revolving credit facility and a $500 million letter of credit facility, according to Investing.com. This substantial credit package increases operational liquidity and provides the company with greater flexibility in managing financial obligations. While such a development would typically enhance financial stability and potentially support sentiment, price action has remained under broader selling pressure.

Technical barriers cap gains as momentum signals favor sellers

On the technical front, CORZ is trading below the MA-20 and MA-50 on the hourly timeframe and is also below the MA-200 on the daily chart. The Ichimoku Kijun is positioned at $17.87, serving as immediate resistance for the stock. Momentum signals show a strong sell from MACD, with ADX remaining neutral. The RSI is at 45.85 and signaling a sell, whereas Stochastic RSI and CCI are both neutral, indicating a lack of clear overbought or oversold conditions. Bull/Bear Power indicates sellers are dominating intraday, while the Awesome Oscillator remains neutral, showing no reinforcement of the present trend.

Downside risks dominate as narrow range consolidation persists

In the short term, the expected price range for CORZ is $16.3 to $17.52, reflecting typical volatility bands relative to current levels. The probability of an upward move is considered very low at less than 20%, while the likelihood of a further decline is high, exceeding 80%. The baseline scenario points to potential sideways consolidation within this range; a decisive move higher would likely need a breakout above $17.87, while a break below $16.3 could trigger additional weakness.

Anton Kharitonov, analyst at Traders Union, notes that despite Core Scientific’s access to $600 million in new credit facilities, price action remains weak. He sees the stock trading below all key moving averages, with intraday momentum pointing to continued selling pressure. Kharitonov maintains a cautious outlook, as market sentiment has not improved even after the positive funding news. "Unless $17.87 is reclaimed, the risk of further downside dominates the short-term picture," he concludes.

Previously it was reported that Core Scientific’s financial position had improved following substantial new credit facilities and a major acquisition, but technical outlooks remained mixed. The current analysis signals a shift toward pronounced downside risk, making a decisive move below $16.3 the key level to watch for further weakness.

Source of Data: CORZ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.